Envestnet Portfolio Solutions Inc. Has $3.09 Million Stake in The Clorox Company (NYSE:CLX)

Envestnet Portfolio Solutions Inc. grew its holdings in The Clorox Company (NYSE:CLX) by 23.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 21,687 shares of the company’s stock after acquiring an additional 4,143 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Clorox were worth $3,092,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Clorox by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock valued at $2,010,622,000 after acquiring an additional 44,344 shares in the last quarter. FMR LLC increased its stake in shares of Clorox by 17.4% in the 3rd quarter. FMR LLC now owns 2,415,054 shares of the company’s stock valued at $316,517,000 after purchasing an additional 357,964 shares during the last quarter. Stifel Financial Corp increased its stake in shares of Clorox by 2.2% in the 3rd quarter. Stifel Financial Corp now owns 2,184,875 shares of the company’s stock valued at $286,356,000 after purchasing an additional 47,879 shares during the last quarter. Morgan Stanley increased its stake in shares of Clorox by 1.8% in the 3rd quarter. Morgan Stanley now owns 1,738,928 shares of the company’s stock valued at $227,904,000 after purchasing an additional 30,902 shares during the last quarter. Finally, Northern Trust Corp increased its stake in shares of Clorox by 2.7% in the 3rd quarter. Northern Trust Corp now owns 1,633,624 shares of the company’s stock valued at $214,103,000 after purchasing an additional 42,352 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.1 %

Shares of NYSE:CLX opened at $138.40 on Thursday. The company has a market capitalization of $17.19 billion, a price-to-earnings ratio of 71.71, a P/E/G ratio of 2.18 and a beta of 0.44. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The business’s 50-day moving average is $146.67 and its 200-day moving average is $144.34. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.33.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the prior year, the business earned $1.51 EPS. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. Equities research analysts predict that The Clorox Company will post 5.83 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 10th. Investors of record on Wednesday, April 24th were paid a dividend of $1.20 per share. This represents a $4.80 dividend on an annualized basis and a yield of 3.47%. The ex-dividend date of this dividend was Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 248.71%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft decreased their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. JPMorgan Chase & Co. reduced their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. UBS Group reduced their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. The Goldman Sachs Group initiated coverage on Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 price objective on the stock. Finally, Evercore ISI reduced their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average target price of $146.43.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.